| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | -48.5% |
| Cost of Revenue | $2.6M | +481.3% |
| R&D Expense | $12.3M | -35.5% |
| SG&A Expense | $20.7M | +62.7% |
| Operating Income | -$38.1M | +3.8% |
| Pre-tax Income | $43.1M | -19.2% |
| Income Tax | $0 | — |
| Net Income | -$43.1M | +19.2% |
| EPS (Basic) | -$1.17 | +63.6% |
| EPS (Diluted) | -$1.17 | +63.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.0M | +1676.4% |
| Accounts Receivable | $1.3M | -46.8% |
| Current Assets | $20.7M | +64.5% |
| Total Assets | $169.6M | +85.7% |
| Current Liabilities | $10.0M | +23.6% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $58.7M | +86.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.4M | -74.9% |
| Investing Cash Flow | -$22.0M | -239.2% |
| Financing Cash Flow | $62.4M | +254.5% |
| $107.6M |
| +80.0% |